Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.05 USD
Change Today -0.08 / -1.94%
Volume 1.5M
GERN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

geron corp (GERN) Key Developments

Geron Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Geron Corporation reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported loss from operations of $9,456,000, net loss of $9,315,000 or $0.06 loss per share on license fees and royalties of $537,000 against loss from operations of $8,731,000, net loss of $8,440,000 or $0.06 loss per share on license fees and royalties of $474,000 for the same period a year ago. The increase in interest and other income in 2015 compared to 2014 was due to higher cash and investment balances in 2015.

Geron Corporation Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 03:40 PM

Geron Corporation Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 03:40 PM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: John A. Scarlett, Chief Executive Officer, President and Director.

Geron Corporation - Shareholder/Analyst Call

Annual Shareholder Meeting

Geron Corporation, Annual General Meeting, May 18, 2015

Geron Corporation, Annual General Meeting, May 18, 2015., at 15:00 Pacific Daylight. Location: Westin San Francisco Airport, One Old Bayshore Highway. Agenda: To elect the two nominees for director named in the accompanying proxy statement to hold office as Class I members of the board of directors until the 2018 annual meeting of stockholders; to approve, on an advisory basis, the compensation of the company's named executive officers; to ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2015; and to transact such other business as may properly come before the annual meeting or any postponement or adjournment thereof.

Geron Corporation Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 05:00 PM

Geron Corporation Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 05:00 PM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: John A. Scarlett, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:US $4.05 USD -0.08

GERN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTime Inc $3.16 USD -0.07
Neuralstem Inc $1.73 USD +0.03
Ocata Therapeutics Inc $4.49 USD +0.24
ReNeuron Group PLC 5.38 GBp -0.25
StemCells Inc $0.41 USD +0.0052
View Industry Companies
 

Industry Analysis

GERN

Industry Average

Valuation GERN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 524.7x
Price/Book 5.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 406.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.